Clinical Pipeline

Central Nervous System

Tardive Dyskinesia

INGREZZA™ (valbenazine) capsules

Pre-Clinical Phase 1 Phase 2 Phase 3 NDA Filed

Tourette Syndrome

INGREZZA (valbenazine) capsules

Pre-Clinical Phase 1 Phase 2 Phase 3 NDA Filed

Essential Tremor

NBI-640756

Pre-Clinical Phase 1 Phase 2 Phase 3 NDA Filed

Parkinson's Disease

Opicapone, Catechol-Omethyltransferase inhibitor (BIAL)

Pre-Clinical Phase 1 Phase 2 Phase 3 NDA Filed

Endocrinology

abbvie_logo

Endometriosis

elagolix

Pre-Clinical Phase 1 Phase 2 Phase 3 NDA Filed
abbvie_logo

Uterine Fibroids

elagolix

Pre-Clinical Phase 1 Phase 2 Phase 3 NDA Filed

Congenital Adrenal Hyperplasia

Pre-Clinical Phase 1 Phase 2 Phase 3 NDA Filed
abbvie_logo

Women's/Men's Health

GnRH Antagonist

Pre-Clinical Phase 1 Phase 2 Phase 3 NDA Filed


CP-NBI-US-0022 02/17